Bullous pemphigoid autoantibodies directly induce blister formation without complement activation

J Immunol. 2014 Nov 1;193(9):4415-28. doi: 10.4049/jimmunol.1400095. Epub 2014 Sep 26.

Abstract

Complement activation and subsequent recruitment of inflammatory cells at the dermal/epidermal junction are thought to be essential for blister formation in bullous pemphigoid (BP), an autoimmune blistering disease induced by autoantibodies against type XVII collagen (COL17); however, this theory does not fully explain the pathological features of BP. Recently, the involvement of complement-independent pathways has been proposed. To directly address the question of the necessity of the complement activation in blister formation, we generated C3-deficient COL17-humanized mice. First, we show that passive transfer of autoantibodies from BP patients induced blister formation in neonatal C3-deficient COL17-humanized mice without complement activation. By using newly generated human and murine mAbs against the pathogenic noncollagenous 16A domain of COL17 with high (human IgG1, murine IgG2), low (murine IgG1), or no (human IgG4) complement activation abilities, we demonstrate that the deposition of Abs, and not complements, is relevant to the induction of blister formation in neonatal and adult mice. Notably, passive transfer of BP autoantibodies reduced the amount of COL17 in lesional mice skin, as observed in cultured normal human keratinocytes treated with the same Abs. Moreover, the COL17 depletion was associated with a ubiquitin/proteasome pathway. In conclusion, the COL17 depletion induced by BP autoantibodies, and not complement activation, is essential for the blister formation under our experimental system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Antigen-Antibody Complex / immunology
  • Autoantibodies / immunology*
  • Autoantigens / immunology
  • Autoantigens / metabolism
  • Blister / immunology*
  • Cell Line
  • Complement Activation / immunology*
  • Complement System Proteins / deficiency
  • Complement System Proteins / immunology*
  • Epitopes / immunology
  • Humans
  • Immunization, Passive
  • Immunoglobulin G / immunology
  • Mice
  • Mice, Transgenic
  • Non-Fibrillar Collagens / immunology
  • Non-Fibrillar Collagens / metabolism
  • Pemphigoid, Bullous / genetics
  • Pemphigoid, Bullous / immunology*
  • Pemphigoid, Bullous / metabolism
  • Pemphigoid, Bullous / pathology*
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Binding / immunology
  • Proteolysis
  • Skin / immunology
  • Skin / metabolism
  • Skin / pathology
  • Ubiquitination

Substances

  • Antigen-Antibody Complex
  • Autoantibodies
  • Autoantigens
  • Epitopes
  • Immunoglobulin G
  • Non-Fibrillar Collagens
  • collagen type XVII
  • Complement System Proteins
  • Proteasome Endopeptidase Complex